The Only Complete Online Marketing Firm
Sunday, March 15, 2015
ACC: TAVR Trials Demonstrate Device Durability (CME/CE)
(MedPage Today) -- CoreValve results improve over time, Sapien benefit holds at 5 years.
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment